Skip to main content
. 2017 Sep 12;7:11408. doi: 10.1038/s41598-017-11628-9

Figure 8.

Figure 8

SOD-3 was required for DXN inhibiting Aβ toxicity. (A) sod-3 expression was up-regulated after 15 mg/mL DXN treatment, and worms were treated with 20 mM juglone as positive control. The scale bar was 40 μm. (B) Quantification of sod-3 expression. (C) 15 mg/mL DXN inhibited the expression of Phsp-16.2::GFP induced by 40 μM juglone, and worms treated with 20 mM juglone were used as positive control. The scale bar was 25 μm. (D) Quantification of the expression of hsp-16.2. In (AD), data are the average of three replicates with about 90 worms in each group. There is significant difference among these groups when symbols are different (P < 0.05). (E) The effects of sod-3 RNAi and hsp16.2 RNAi on DXN inhibiting worm paralysis induced by Aβ1-42 over-expression. Data are the average of three replicates with about 120–180 worms in each group. ***Indicated that there was significant difference between treatment groups and control group at P < 0.001.